Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Share News (VER)

  • There is currently no data for VER

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 14th Aug 2014 09:39

Admiral Group: Deutsche Bank reduces target price from 1330p to 1260p and maintains a hold recommendation.Balfour Beatty: Deutsche Bank lowers target price from 250p to 245p keeping its hold recommendation.Betfair: Jefferies raises target price from 1175p to 1230p maintaining a buy recommendation.Brit: Canaccord Genuity shifts target price from 255p to 260p and reiterates a buy recommendation.Centamin: Westhouse Securities shifts target price from 60p to 65p retaining its neutral rating.EnQuest: UBS cuts target price from 144p to 125p staying with its neutral rating.Firestone Diamonds: FinnCap initiates with a target price of 84p and a buy recommendation.GAME Digital: Canaccord Genuity ups target price from 250p to 270p staying with its buy recommendation.Glencore Xstrata: Investec ups target price from 319p to 360p and retains a hold recommendation. Credit Suisse downgrades from outperform to neutral with a target price of 380p.Intermediate Capital Group: Numis ups target price from 363p to 375p upgrading from reduce to hold.Monitise: Berenberg cuts target price from 74p to 42p and keeps a hold recommendation.Ophir Energy: Westhouse Securities reduces target price from 290p to 245p keeping an add rating.Vernalis: Canaccord Genuity shifts target price from 52p to 54p and retains a buy recommendation.W Resources: Northland initiates with a target price of 2.2p and a buy recommendation.Serco Group: Berenberg cuts target price from 340p to 310p staying with its hold recommendation.Synergy Health: Investec increases target price from 1565p to 1607p and maintains a buy recommendation.
More News
26 Apr 2016 11:38

UPDATE: Backed By CEO And Investors, Vernalis Raises GBP40 Million (ALLISS)

Read more
26 Apr 2016 10:22

Vernalis Eyes US Cough Cold Market With GBP40 Million Fundraising (ALLISS)

Read more
21 Apr 2016 14:44

Vernalis hires AstraZeneca marketeer to lead Tuzistra operation in US

(ShareCast News) - Vernalis has appointed 24-year AstraZeneca veteran Sandford 'Sandy' Sommer as president and chief operating officer of its US operation, Vernalis Therapeutics. Sommer most recent role was as president of AstraZeneca's Colombia operations, following a variety of leadership roles, i

Read more
21 Apr 2016 13:30

Vernalis Taps AstraZeneca Veteran Sommer For US Business

Read more
14 Apr 2016 08:06

Vernalis Says CCP-07 Study Completed, On Track For Application

Read more
13 Apr 2016 07:43

Vernalis Completes Single-Dose Study For Cough And Cold Product

Read more
17 Mar 2016 12:12

Vernalis drops into red after investment in cough treatment

(ShareCast News) - Shares in Vernalis sank to an 11-month low after the biotech company posted a half-year loss as its first prescription cough cold product, Tuzistra XR, launched during what has proved a very mild flu season in the USA. Revenue was up 7% to £6.1m in the six months to 31 December, b

Read more
17 Mar 2016 10:54

Vernalis Interim Loss Widens As Spending Rises On Launch Of Tuzistra

Read more
10 Mar 2016 16:07

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 Jan 2016 08:40

Vernalis Reveals US-Based Corvus Pharmaceuticals As Licensee

Read more
21 Dec 2015 11:21

Vernalis Says Cough Cold Drug CCP-07 Completes Single-Dose Study

Read more
2 Dec 2015 10:37

Vernalis Confident After Tuzistra Launch And Moxatag Acquisition

Read more
25 Nov 2015 16:14

AGM, EGM Calendar - Week Ahead

Read more
12 Oct 2015 09:58

Vernalis Says Tris Pharma Begins Stability Testing Of CCP-08

Read more
2 Oct 2015 16:31

Vernalis acquires rights to Pragma's MOXATAG treatment

(ShareCast News) - Pharmaceutical group Vernalis has completed the acquisition of the US rights to the amoxicillin extended-release tablet brand MOXATAG from Pragma Pharmaceuticals. The London-listed company said it has made an undisclosed up-front payment in cash for the rights, with a further paym

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.